Sikkim, India
SEARCH FILTERS
Time filter
Source Type

News Article | April 24, 2017
Site: www.acnnewswire.com

CropLife Asia Awarded for New Approach to Farmer Communication CropLife Asia took home an Asia Pacific Excellence Award 2016, Non-Governmental Organizations & Associations category, at a ceremony held on 19 April 2017 at the Harbour Grand Kowloon in Hong Kong. Through the 'Madhu Sandesh' program, farmers in the state of Maharashtra, India are provided rental bee hives to ensure pollination of their crops. This not only results in improved yield and incomes for farmers but also instills a holistic understanding of the need to use crop protection products in a manner that protects the environment, ecosystems, and human health. At the end of the first year, 90% of the 180 program participants reported better quality crops. Pomegranate farmers saw an average of 35% increase in their yields, corresponding to a 42% increase in income while the training they received helped reduce waste. Moreover, the farmers who benefitted from the program became greater advocates of promoting pollination, protecting the environment and using crop protection products responsibly. The programme continues to enroll more participants as it moves into its second year. "We are extremely proud to receive this recognition, which was made possible thanks to the effort and excellent teamwork of our partners ICAR and KVK Baramati," said Dr Siang Hee Tan, Executive Director of CropLife Asia. "The onus is on us to ensure farmers across the region are able to produce more food for a growing population with fewer resources as well as less impact on the environment - and realize the better quality of life that comes with higher yields. The 'Madhu Sandesh' project shows us an effective way to engage farmers with our core message on responsible use, and to ensure they spread this message in their communities." To find out more about the 'Madhu Sandesh' project, please watch this video at the following domain: https://www.youtube.com/watch?v=6QY1FOFqZo0. The Asia Pacific Excellence Awards are organized by Communication Director, a global magazine for corporate communications and public relations, and celebrate the most outstanding achievements of professionals and organizations in the field. Please visit https://ap-pr.excellence-awards.com/. About CropLife Asia CropLife Asia is a non-profit society and the regional organization of CropLife International, the voice of the global plant science industry. We advocate a safe, secure food supply, and our vision is food security enabled by innovative agriculture. CropLife Asia supports the work of 15 member associations across the continent and is led by eight member companies at the forefront of crop protection, seeds and/or biotechnology research and development. For more information, visit us at www.croplifeasia.org. Contact:


More than one-third of adults in the U.S. have obesity, and overweight and obesity-related conditions including heart disease, stroke, type 2 diabetes, and certain types of cancer are the second leading cause of preventable death in the U.S., following tobacco. Obesity is a chronic metabolic disease that must be managed appropriately to reduce the risk of serious health conditions. "We are happy to support such a respected institution for clinical research that will improve surgical outcomes and advance the practice of weight-loss medicine", states Anthony Tabasso, President and Chief Executive Officer of KVK Tech. "KVK is the leading manufacturer of FDA-approved medicines for the obesity patient in the U.S. and committed to advancing weight-management strategies through research discoveries to provide an evidence-based understanding of obesity." The obesity epidemic is a complex problem that requires a multifaceted approach to the appropriate care and management of patients. People who are overweight or obese have a much greater risk of developing serious conditions that will increase overall healthcare costs. "Anytime we can support research on the causes and consequences of overweight and obesity that may result in potential prevention and treatment strategies, it's a win for many stakeholders," added Mr. Tabasso. KVK is a leader in the development and manufacture of high-quality, FDA-approved medicines that address unmet patient needs.  Founded in 2004, KVK takes pride in its ability to advance medical care and offer low-cost alternatives in response to today's healthcare challenges. KVK manufactures and distributes Lomaira™ (phentermine hydrochloride USP) 8 mg tablets CIV. All of KVK's products are made in the U.S.A. in a state-of-the-art facility in Newtown, PA. www.kvktech.com. For more information and full prescribing information, visit www.lomaira.com.


Argentum is a generic drug company with core competencies in intellectual property and pharmaceutical operations. By working with branded and generic pharmaceutical companies and healthcare payors, Argentum intends to reduce the overall cost of prescription drugs by challenging patents that are not innovative and which artificially support high drug prices.  www.argentumpharmaceuticals.com KVK is a recognized leader in the development and manufacture of high-quality, FDA-approved medicines, and possesses operational expertise in pharmaceutical manufacturing, packaging, sales, distribution, research & development, and customer service. KVK's expertise runs the gamut and includes solid oral, powder, liquid, and proprietary dosage technologies.  KVK is in the process of expanding its capabilities into aseptic products as well with a 225,000 sq./ft. sterile injectable facility being qualified this year.  KVK takes pride in its ability to advance medical care and offer low-cost, high-quality alternatives in response to today's healthcare challenges.  KVK is one of the few manufacturers of generic pharmaceuticals which does all its manufacturing, packaging, and distribution in the United States. www.kvktech.com


About Argentum Pharmaceuticals Argentum is a generic drug company with core competencies in intellectual property and pharmaceutical operations. By working with branded and generic pharmaceutical companies and healthcare payors, Argentum intends to reduce the overall cost of prescription drugs by challenging patents that are not innovative and which artificially support high drug prices.  www.argentumpharmaceuticals.com About KVK Tech KVK is a recognized leader in the development and manufacture of high-quality, FDA-approved medicines, and possesses operational expertise in pharmaceutical manufacturing, packaging, sales, distribution, research & development, and customer service. KVK's expertise runs the gamut and includes solid oral, powder, liquid, and proprietary dosage technologies.  KVK is in the process of expanding its capabilities into aseptic products as well with a 225,000 sq./ft. sterile injectable facility being qualified this year.  KVK takes pride in its ability to advance medical care and offer low-cost, high-quality alternatives in response to today's healthcare challenges.  KVK is one of the few manufacturers of generic pharmaceuticals which does all its manufacturing, packaging, and distribution in the United States. www.kvktech.com


Afield experiment was carried out during summer 2013 at Bajaura (Kullu) Himachal Pradesh to find the efficacy of different plant extracts and biopesticides against lepidopterous insect pests attacking cabbage crop. The results revealed that though the highest mortality (100%) of the lepidopterous caterpillars was recorded at 3 days after treatment (DAT) containing chemical pesticides (T4) yet both the biopesticidal formulations viz. T, (Melia 5% formulation@ 5 ml/L) and T3(Neemban (0.15%) @ 5ml/L and treatment with plant extractie. T2 (extract of the mixture of leaves of 5 plants) were also equally effective resulting in 82.16, 82.23 and 80.00 per mortality of the larvae (early instars), respectively following first spray and 79.75, 75.62 and 75.94 per mortality after 3 days of the second spray. Data on the yield and yield attributing parameters of cabbage showed that the proportion of unmarketable heads of cabbage under respective treatments T1, T3 and T2 was 7.87, 8.40 and 7.72 per cent as compared to 44.00 per cent in the control and the marketable yields recorded from these treatments were also significantly higher than the control and statistically at par with each other, i.e. 459.95, 439.15 and 462.95 q/ha as compared to 224.02 q/ha in the control. Yield loss underthese treatments was 3.12, 3.50 and 2.72 per cent, respectively as compared to 35.14 per cent in the control.


Calamus tenuis (Roxb.), a versatile, dioecious rattan species predominant in northeast India, has emerged as an economical material for light furniture and cottage industries. For the genetic improvement of the species, it is essential to be able to recognize male and female plants at the seedling stage. Screening of genomic DNA with inter-simple sequence repeat (ISSR) primers was used to discover sex-specific polymerase chain reaction (PCR) amplification products. Thirty ISSR primers were screened on female and male C. tenuis plants from five different provinces of Assam, India. A putative female-specific marker was identified. The applicability of ISSR-PCR analysis for development of sex-linked molecular markers in Calamus is discussed. © 2010 Springer Science+Business Media B.V.


Patent
KVK Inc | Date: 2014-06-04

Formulations capable of extended or sustained release of high levels of caffeine or analogs, derivatives and metabolites thereof have been developed The formulations contain at least two components capable of releasing the caffeine or related compound differing rates to maintain a desired plasma level.


Trademark
KVK Inc | Date: 2016-08-12

pharmaceutical preparations for treatment of allergies, namely, chlorpheniramine maleate extended-release antihistamine tablets.


Trademark
KVK Inc | Date: 2016-06-07

Antihistamines; Pain relief medication; Pharmaceutical agents affecting metabolism; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations for the treatment of tissue inflammation; Pharmaceutical preparations for hyperkalemia; Pharmaceutical preparations, namely, appetite suppressants. Pharmaceutical products development.


Loading KVK Inc collaborators
Loading KVK Inc collaborators